Rejuvenan Global Health, Inc.

Rejuvenan Global Health, Inc. is a United States based health care startup that has developed a unique digital personal health platform for corporate wellness and health. The company's mission is to utilize digital interventions to deliver clinically proven behavioral modifications to prevent, treat, and reverse lifestyle-induced chronic diseases. At the core of Rejuvenan's platform are two proprietary sets of algorithms based on the 2009 Nobel Prize-winning science of telomere biology: a Risk Detection Engine and a Treatment Recommendation Engine. These algorithms provide curated, personalized coaching and interactive tools to drive behavioral change through the adoption of a healthy lifestyle. This is shown to reduce or reverse future disease risk and alter gene expression patterns for the better. Rejuvenan's health platform collects data from users' smart devices, blood tests, and direct input. The platform utilizes a 10-biomarker health assessment to deliver personalized coaching to improve nutrition, exercise, stress management, and social support behaviors. This personalized approach is proven to lengthen telomeres, which is considered the ultimate measure of health. The startup secured a $3.48M Venture Round investment on May 22, 2014. With its innovative approach to personalized health and wellness, Rejuvenan Global Health is poised to make significant strides in the corporate wellness and healthcare industries.